These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

213 related articles for article (PubMed ID: 6184304)

  • 1. Cloned T lymphocytes and monoclonal antibodies as probes for cell surface molecules active in T cell-mediated cytolysis.
    Sarmiento M; Dialynas DP; Lancki DW; Wall KA; Lorber MI; Loken MR; Fitch FW
    Immunol Rev; 1982; 68():135-69. PubMed ID: 6184304
    [No Abstract]   [Full Text] [Related]  

  • 2. Clonal heterogeneity in the functional requirement for Lyt-2/3 molecules on cytolytic T lymphocytes (CTL): possible implications for the affinity of CTL antigen receptors.
    MacDonald HR; Glasebrook AL; Bron C; Kelso A; Cerottini JC
    Immunol Rev; 1982; 68():89-115. PubMed ID: 6184308
    [No Abstract]   [Full Text] [Related]  

  • 3. Effects of anti-Lyt-2 and anti-L3T4 monoclonal antibodies on the function of cytotoxic T lymphocyte/helper T lymphocyte hybrid T cell clones.
    Havran WL; Fitch FW
    J Immunol; 1988 Sep; 141(6):1808-12. PubMed ID: 2459190
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Requirement for the involvement of clonally distributed receptors in the activation of cytotoxic T lymphocytes.
    Larsson EL; Gullberg M; Beretta A; Coutinho A
    Immunol Rev; 1982; 68():67-88. PubMed ID: 6184307
    [No Abstract]   [Full Text] [Related]  

  • 5. Molecular interactions in T-cell-mediated cytotoxicity.
    Bonavida B; Bradley T; Fan J; Hiserodt J; Effros R; Wexler H
    Immunol Rev; 1983; 72():119-41. PubMed ID: 6192075
    [No Abstract]   [Full Text] [Related]  

  • 6. Requirement for Lyt-2/3 molecules on allospecific cytolytic T lymphocyte clones is dependent upon target cell antigen density.
    Shimonkevitz R; Cerottini JC; MacDonald HR
    Adv Exp Med Biol; 1985; 184():343-53. PubMed ID: 2931001
    [No Abstract]   [Full Text] [Related]  

  • 7. Clonal analysis of cytolytic T lymphocyte-mediated lysis of target cells with inducible antigen expression: correlation between antigen density and requirement for Lyt-2/3 function.
    Shimonkevitz R; Luescher B; Cerottini JC; MacDonald HR
    J Immunol; 1985 Aug; 135(2):892-9. PubMed ID: 2409156
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Variable requirement for murine lymphocyte function-associated antigen-1 (LFA-1) in T cell-mediated lysis depending upon the tissue origin of the target cells.
    Shimonkevitz R; Cerottini JC; MacDonald HR
    J Immunol; 1985 Sep; 135(3):1555-7. PubMed ID: 3160769
    [No Abstract]   [Full Text] [Related]  

  • 9. A clone-specific monoclonal antibody that inhibits cytolysis of a cytolytic T cell clone.
    Lancki DW; Lorber MI; Loken MR; Fitch FW
    J Exp Med; 1983 Mar; 157(3):921-35. PubMed ID: 6187881
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antigens involved in mouse cytolytic T-lymphocyte (CTL)-mediated killing: functional screening and topographic relationship.
    Sanchez-Madrid F; Davignon D; Martz E; Springer TA
    Cell Immunol; 1982 Oct; 73(1):1-11. PubMed ID: 6983917
    [No Abstract]   [Full Text] [Related]  

  • 11. Induction and blocking of cytolysis in CD2+, CD3- NK and CD2+, CD3+ cytotoxic T lymphocytes via CD2 50 KD sheep erythrocyte receptor.
    Bolhuis RL; Roozemond RC; van de Griend RJ
    J Immunol; 1986 Jun; 136(11):3939-44. PubMed ID: 3084649
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cell surface molecules involved in NK recognition by cloned cytotoxic T lymphocytes.
    Brooks CG; Holscher M
    J Immunol; 1987 Mar; 138(5):1331-7. PubMed ID: 3543127
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Lymphoid cell surface interaction structures detected using cytolysis-inhibiting monoclonal antibodies.
    Golstein P; Goridis C; Schmitt-Verhulst AM; Hayot B; Pierres A; van Agthoven A; Kaufmann Y; Eshhar Z; Pierres M
    Immunol Rev; 1982; 68():5-42. PubMed ID: 6184306
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Specificity of OKT4+ cytotoxic T lymphocyte clones.
    Krensky AM; Clayberger C; Reiss CS; Strominger JL; Burakoff SJ
    J Immunol; 1982 Nov; 129(5):2001-3. PubMed ID: 6181153
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Characterization of monoclonal antibodies against cell surface molecules associated with cytotoxic activity of natural and activated killer cells and cloned CTL lines.
    Spits H; Keizer G; Borst J; Terhorst C; Hekman A; de Vries JE
    Hybridoma; 1983; 2(4):423-37. PubMed ID: 6332061
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Characterization of the murine T cell surface molecule, designated L3T4, identified by monoclonal antibody GK1.5: similarity of L3T4 to the human Leu-3/T4 molecule.
    Dialynas DP; Quan ZS; Wall KA; Pierres A; Quintáns J; Loken MR; Pierres M; Fitch FW
    J Immunol; 1983 Nov; 131(5):2445-51. PubMed ID: 6415170
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Blocking of effector cell cytotoxicity and T-cell proliferation by Lyt antisera.
    Nakayama E
    Immunol Rev; 1982; 68():117-34. PubMed ID: 6757106
    [No Abstract]   [Full Text] [Related]  

  • 18. Role of accessory molecules in signal transduction of cytolytic T lymphocyte by anti-T cell receptor and anti-Ly-6.2C monoclonal antibodies.
    Leo O; Foo M; Henkart PA; Perez P; Shinohara N; Segal DM; Bluestone JA
    J Immunol; 1987 Dec; 139(11):3556-63. PubMed ID: 3316387
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A rat anti-mouse T4 monoclonal antibody (H129.19) inhibits the proliferation of Ia-reactive T cell clones and delineates two phenotypically distinct (T4+, Lyt-2,3-, and T4-, Lyt-2,3+) subsets among anti-Ia cytolytic T cell clones.
    Pierres A; Naquet P; Van Agthoven A; Bekkhoucha F; Denizot F; Mishal Z; Schmitt-Verhulst AM; Pierres M
    J Immunol; 1984 Jun; 132(6):2775-82. PubMed ID: 6202760
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clonal heterogeneity in the functional requirement for Lyt-2/3 molecules on cytolytic T lymphocytes: analysis by antibody blocking and selective trypsinization.
    MacDonald HR; Glasebrook AL; Cerottini JC
    J Exp Med; 1982 Dec; 156(6):1711-22. PubMed ID: 6983559
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.